Randomized comparative bioavailability of a novel 3D printed fast melt formulation of levetiracetam following the administration of a single 1000 mg dose to healthy human volunteers under fasting and fed conditions

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

In June 2016, the National Institutes of Health (NIH) released a new policy on the use of a

Subscribe to